换一批
换一批Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.
第一作者：
Massimo,Colombo
第一单位：
From Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Gilead Sciences, Foster City, California; Hôpital Saint Joseph, Marseilles, and Hôpital Cochin, Paris, France; Medical University of Vienna, Vienna, Austria; and Hannover Medical School, Hannover, Germany.
作者：
主题词
成年人(Adult);老年人(Aged);抗病毒药(Antiviral Agents);苯咪唑类(Benzimidazoles);用药计划表(Drug Administration Schedule);抗药性, 病毒(Drug Resistance, Viral);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);芴类(Fluorenes);基因型(Genotype);肾小球滤过率(Glomerular Filtration Rate);丙型肝炎, 慢性(Hepatitis C, Chronic);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged)
DOI
10.7326/M16-1205
PMID
27842383
发布时间
2022-03-31
- 浏览14
Annals of internal medicine
109-117页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
